Biocon’s target factory

Thomas X. Neenan; Robert E. Burrier; Sunghoon Kim

doi:10.1038/nbt.4242

Biocon’s target factory

Thomas X. Neenan, Robert E. Burrier, Sunghoon Kim

Department of Pharmacy

Research output: Contribution to journal › Comment/debate › peer-review

5 Citations (Scopus)

Abstract

South Korea’s 8-year effort to create an integrated platform for novel target and lead development provides an academic drug discovery model for other emerging economies.

Original language	English
Pages (from-to)	791-797
Number of pages	7
Journal	Nature Biotechnology
Volume	36
Issue number	9
DOIs	https://doi.org/10.1038/nbt.4242
Publication status	Published - 2018 Sept 6

Bibliographical note

Funding Information:
This work was supported by a Global Frontier Project grant (NRF-M3A6A4-2010-0029785).

Publisher Copyright:
© 2018, Nature Publishing Group. All rights reserved.

All Science Journal Classification (ASJC) codes

Biotechnology
Bioengineering
Applied Microbiology and Biotechnology
Molecular Medicine
Biomedical Engineering

Access to Document

10.1038/nbt.4242

Cite this

@article{6b2d33a5fb4d4d979e1afc75272ab761,

title = "Biocon{\textquoteright}s target factory",

abstract = "South Korea{\textquoteright}s 8-year effort to create an integrated platform for novel target and lead development provides an academic drug discovery model for other emerging economies.",

author = "Neenan, {Thomas X.} and Burrier, {Robert E.} and Sunghoon Kim",

note = "Funding Information: This work was supported by a Global Frontier Project grant (NRF-M3A6A4-2010-0029785). Publisher Copyright: {\textcopyright} 2018, Nature Publishing Group. All rights reserved.",

year = "2018",

month = sep,

day = "6",

doi = "10.1038/nbt.4242",

language = "English",

volume = "36",

pages = "791--797",

journal = "Bio/Technology",

issn = "1087-0156",

publisher = "Nature Publishing Group",

number = "9",

}

TY - JOUR

T1 - Biocon’s target factory

AU - Neenan, Thomas X.

AU - Burrier, Robert E.

AU - Kim, Sunghoon

PY - 2018/9/6

Y1 - 2018/9/6

N2 - South Korea’s 8-year effort to create an integrated platform for novel target and lead development provides an academic drug discovery model for other emerging economies.

AB - South Korea’s 8-year effort to create an integrated platform for novel target and lead development provides an academic drug discovery model for other emerging economies.

UR - http://www.scopus.com/inward/record.url?scp=85053082783&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85053082783&partnerID=8YFLogxK

U2 - 10.1038/nbt.4242

DO - 10.1038/nbt.4242

M3 - Comment/debate

C2 - 30188545

AN - SCOPUS:85053082783

SN - 1087-0156

VL - 36

SP - 791

EP - 797

JO - Bio/Technology

JF - Bio/Technology

IS - 9

ER -

Biocon’s target factory

Abstract

Bibliographical note

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this